Literature DB >> 3571210

Selective release of phospholipase A2 and lysophosphatidylserine-specific lysophospholipase from rat platelets.

K Horigome, M Hayakawa, K Inoue, S Nojima.   

Abstract

Rat platelets released phospholipase A2 and lysophospholipase upon activation with thrombin or ADP. The release of phospholipases was energy-dependent and was not in parallel with that of a known lysosomal marker enzyme, N-acetyl-beta-D-glucosaminidase. The phospholipases are derived from other granules (dense granules or alpha-granules) rather than lysosomal granules of the cells. All of the activities of both phospholipases in the cell free fraction obtained from the activated platelet reaction mixture was recovered in the supernatant after centrifugation at 105,000 X g. The degree of hydrolysis of phospholipids by the phospholipase A2 followed the order: phosphatidylethanolamine (PE) greater than phosphatidylserine (PS) greater than phosphatidylcholine (PC). Phospholipase A2 shows a broad pH optimum (greater than pH 7.0) and absolutely requires Ca2+. Lysophospholipase was specific to lysophosphatidylserine (lysoPS), and neither lysophosphatidylethanolamine (lysoPE) nor lysophosphatidylcholine (lysoPC) was hydrolyzed appreciably. Both 1-acyl- and 2-acyl-lysophosphatidylserine were equally hydrolyzed. Lysophospholipase activity shows similar pH optimum to phospholipase A2. The lysophospholipase activity was lost easily at 60 degrees C. The activity was reduced by the presence of EDTA, though low but distinct activity was observed even in the presence of EDTA. Addition of Ca2+ to the mixtures restores the full activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3571210     DOI: 10.1093/oxfordjournals.jbchem.a121907

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  15 in total

1.  Pharmacokinetic characterization of phosphatidylserine liposomes in the rat.

Authors:  P Palatini; G Viola; E Bigon; A M Menegus; A Bruni
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

2.  Cyclic AMP mimics, but does not mediate, interleukin-1- and tumour-necrosis-factor-stimulated phospholipase A2 secretion from rat renal mesangial cells.

Authors:  J Pfeilschifter; J Leighton; W Pignat; F Märki; K Vosbeck
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

3.  Human recombinant platelet phospholipase A2 exacerbates poly-L-arginine induced rat paw edema.

Authors:  G Cirino; C Cicala; L Sorrentino
Journal:  Inflammation       Date:  1994-02       Impact factor: 4.092

4.  Rat liver mitochondrial phospholipase A2 is an endotoxin-stimulated membrane-associated enzyme of Kupffer cells which is released during liver perfusion.

Authors:  G M Hatch; D E Vance; D C Wilton
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

Review 5.  Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.

Authors:  W Lee Titsworth; Nai-Kui Liu; Xiao-Ming Xu
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

Review 6.  Aiming drug discovery at lysophosphatidic acid targets.

Authors:  Gabor Tigyi
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

7.  Human platelets release a paf-acether: acetylhydrolase similar to that in plasma.

Authors:  R Korth; J Bidault; R Palmantier; J Benveniste; E Ninio
Journal:  Lipids       Date:  1993-03       Impact factor: 1.880

8.  Extracellular phospholipase A2 detected at inflamed sites in rats does not originate from platelets.

Authors:  H Mori; S Hara; H Mizushima; I Kudo; Y Sato; K Inoue
Journal:  Agents Actions       Date:  1991-03

9.  The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2.

Authors:  Y Weinrauch; P Elsbach; L M Madsen; A Foreman; J Weiss
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

10.  Effect of ethanol on platelet phospholipase A2.

Authors:  C D Stubbs; R Rubin
Journal:  Lipids       Date:  1992-04       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.